Navigation Links
New Vaccine May Work Better Against Lung Disease
Date:9/9/2009

Different formulation seems to thwart pneumonia in high-risk group with COPD, study finds

WEDNESDAY, Sept. 9 (HealthDay News) -- A recently developed pneumonia vaccine may be more effective in preventing infections in patients with chronic obstructive pulmonary disease (COPD) than the vaccine that is typically used, new research suggests.

Risk of pneumonia can be an ongoing problem for people with COPD, a chronic, progressive disease that causes difficulty breathing and chest tightness. The U.S. Centers for Disease Control and Prevention recommends that all adults with COPD be vaccinated against pneumonia with a vaccine referred to as PPSV23 (23-valent pneumococcal polysaccharide vaccination).

But the effectiveness of the vaccine in people with COPD hasn't been sufficiently proven, according to the study that will appear in the Sept. 15 issue of the American Journal of Respiratory and Critical Care Medicine.

"Reasonable effectiveness for this vaccine has been demonstrated in cohort studies in adults with lung disease," said study author Dr. Mark Dransfield of the University of Alabama at Birmingham, in a news release from the American Thoracic Society. "[However,] debate remains about its immunogenicity and effectiveness in COPD."

In the current study, researchers inoculated 120 adults with moderate to severe COPD with either PPSV23 or a newer vaccine, PCV7.

Several indicators showed the PCV7 vaccine produced a heightened immune response as compared to the older vaccine.

The blood of patients who had received PCV7 vaccine was also more effective at killing pneumonia-causing bacteria in six of seven serotypes, or groups of microorganisms, one month after vaccination, the researchers found.

"We have shown that PCV7 induces a superior immune response to PPSV23 in COPD at one month post-vaccination," Dransfield stated in the news release.

However, older age and prior vaccination with PPSV23 blunted the efficacy of the PCV7 vaccine, the researchers noted, and further study is needed.

More information

The National Heart, Lung, and Blood Institute has more on COPD.



--Jennifer Thomas



SOURCE: American Thoracic Society, news release, Sept. 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Panel Weighs Approving HPV Vaccine for Males
2. Vaxart Awarded NIH Grant to Support Development of Orally-Delivered H5N1 Avian Influenza Vaccine
3. Offits Failure to Disclose Jeopardizes Swine Flu Vaccine Program
4. Swine Flu Vaccine Seems Safe: Experts
5. Discoveries Brighten Search for AIDS Vaccine
6. HPV vaccine could prevent breast cancer: Australian research
7. Pennsylvania Department of Health Launches Online H1N1 Vaccine Registry
8. Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine?
9. Sinovacs H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
10. IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests
11. Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Vaccine May Work Better Against Lung Disease
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced ... test throughout the Northeast U.S. , GlycoMark is the only clinically available ... test provides a clinically proven one- to two-week measure of hyperglycemic excursions, often ...
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain ... After Tina Howe joined the team, the Bill Howe brand was born and they ... rates, and giving back to the San Diego community in which they worked, lived ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/27/2017)... ... 27, 2017 , ... Today, Jefferson Health in Philadelphia and ... an agreement to create the Jane and Leonard Korman Respiratory Institute in Philadelphia. ... Korman Family Foundation. The collaboration leverages the strengths of each organization and will ...
Breaking Medicine News(10 mins):
(Date:4/26/2017)... PROVIDENCE, N.J. , April 26, 2017 Phoenix ... announce its fifteenth year of fulfilling its mission of transforming ... industry is highly scrutinized, Phoenix,s innovative ... the healthcare community about the latest advances in science and ... Phoenix was founded in 2002 by ...
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
Breaking Medicine Technology: